EEOC Delays Collection of 2019 EEO-1 Data Until 2021
Client Alert | 1 min read | 05.08.20
On May 7, 2020, the U.S. Equal Employment Opportunity Commission (EEOC) announced that it will delay its collection of 2019 EEO-1 Component 1 data collection until 2021, in recognition of challenges currently facing employers given the Coronavirus Disease 2019 (COVID-19) pandemic. The EEOC anticipates that it will begin collecting 2019 and 2020 EEO-1 Component 1 data in March, 2021, and will notify filers of the precise date on which they may begin filing as soon as that information is available. Despite the temporary reprieve, employers should continue to collect and maintain the necessary race, ethnicity, gender, and EEO-1 category data required to complete the report. Last Fall, the EEOC stated that it would not seek Office of Management and Budget (OMB) approval to collect the “Component 2” compensation and hours data it was ultimately required to collect for 2017 and 2018, so employers will only need to submit Component 1 demographic data when filing resumes.
Contacts
Insights
Client Alert | 4 min read | 12.04.25
District Court Grants Preliminary Injunction Against Seller of Gray Market Snack Food Products
On November 12, 2025, Judge King in the U.S. District Court for the Western District of Washington granted in part Haldiram India Ltd.’s (“Plaintiff” or “Haldiram”) motion for a preliminary injunction against Punjab Trading, Inc. (“Defendant” or “Punjab Trading”), a seller alleged to be importing and distributing gray market snack food products not authorized for sale in the United States. The court found that Haldiram was likely to succeed on the merits of its trademark infringement claim because the products at issue, which were intended for sale in India, were materially different from the versions intended for sale in the U.S., and for this reason were not genuine products when sold in the U.S. Although the court narrowed certain overbroad provisions in the requested order, it ultimately enjoined Punjab Trading from importing, selling, or assisting others in selling the non-genuine Haldiram products in the U.S. market.
Client Alert | 21 min read | 12.04.25
Highlights: CMS’s Proposed Rule for Medicare Part C & D (CY 2027 NPRM)
Client Alert | 11 min read | 12.01.25
